Summary:
Horizon Clinical Research Associates is conducting a research study for Type 2 Diabetes Mellitus.
Qualified Participants Must:
• Be male or female
•
Be 18 years or older at the time of signing informed consent
•
Insulin-naïve subjects diagnosed with type 2 diabetes and on stable diabetes treatment with metformin or metformin and SU (metformin 1500 mg or higher or maximum tolerated dose and SU half of maximum allowed dose according to national label or higher) for at least 90 days before screening. Stable is defined as unchanged medication and unchanged dose
•
Have HbA1c between 7.0 and 10.0% (53 - 86 mmol/mol) (both inclusive)